CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 1/2a Multi-Center, Dose-Escalation Study to Evaluate the Safety & Efficacy of Eyecyte-RPE™ When Administered as a Single-dose Subretinal Injection in Subjects With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06394232
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:11.201006+00:00
- Published At
- 2024-09-24T00:00:00+00:00
- Record Updated At
- 2024-09-24
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Retinal Disease", "Macular Degeneration", "Age-Related Macular Degeneration", "Geographic Atrophy", "Eye Diseases"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-09-24"- protocolSection.identificationModule.nctId
"NCT06394232"- protocolSection.identificationModule.officialTitle
"A Phase 1/2a Multi-Center, Dose-Escalation Study to Evaluate the Safety \u0026 Efficacy of Eyecyte-RPE\u2122 When Administered as a Single-dose Subretinal Injection in Subjects With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.